QRM 008
Alternative Names: QRM-008Latest Information Update: 28 Jul 2023
At a glance
- Originator Qrumpharma
- Class Antituberculars
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Nontuberculous mycobacterium infections; Tuberculosis
Most Recent Events
- 28 Jul 2023 No recent reports of development identified for preclinical development in Nontuberculous-mycobacterium-infections in USA (Inhalation)
- 28 Jul 2023 No recent reports of development identified for preclinical development in Tuberculosis in USA (Inhalation)
- 09 Jun 2019 Preclinical trials in Nontuberculous mycobacterium infections in USA (Inhalation) before February 2021 (https://web.archive.org/web/20190609205104/http://www.qrumpharma.com/)